Taxol inhibits progression of congenital polycystic kidney disease
Polycystic kidney diseases (PKD) are the most common hereditary diseases of the human kidney and account for ten per cent of patients requiring renal transplantation or dialysis. Renal cyst formation has been attributed to enhanced cell proliferation, unbalanced cell death, abnormal targeting of mem...
Gespeichert in:
| Veröffentlicht in: | Nature (London) 1994-04, Vol.368 (6473), p.750-753 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 753 |
|---|---|
| container_issue | 6473 |
| container_start_page | 750 |
| container_title | Nature (London) |
| container_volume | 368 |
| creator | Woo, David D. L Miao, Steven Y. P Pelayo, Juan C Woolf, Adrian S |
| description | Polycystic kidney diseases (PKD) are the most common hereditary diseases of the human kidney and account for ten per cent of patients requiring renal transplantation or dialysis. Renal cyst formation has been attributed to enhanced cell proliferation, unbalanced cell death, abnormal targeting of membrane proteins, aberrant kidney development and tubular obstruction, but there is no treatment that blocks the formation and enlargement of renal cysts. We have now developed an in vitro model of spontaneous cyst formation that distinguishes polycystic kidney epithelium from its normal counterpart. Inhibitors of DNA, RNA and protein synthesis did not prevent in vitro cyst formation, but this was reversibly inhibited by ouabain, amiloride and the microtubule-specific agents colchicine, vinblastine and taxol. The cpk mouse is a well-characterized recessive PKD model and we find that cpk/cpk mice develop PKD and die from uraemia by 4-5 weeks of age, but when treated weekly with taxol they survive for more than 200 days with minimal loss of renal function, show limited collecting-dust cyst enlargement, and attain adult size. Our results indicate that the microtubule cytoskeleton has a central role in the pathogenesis of PKD in cpk mice and that taxol may also be useful in treating human PKD. |
| doi_str_mv | 10.1038/368750a0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76438942</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4951951</sourcerecordid><originalsourceid>FETCH-LOGICAL-c388t-a1d6bcf986fabf9701ee49b51c72a0033091d54eac79266e1195e9030417737f3</originalsourceid><addsrcrecordid>eNqF0Mtq3DAUBmBRGpJJWugLJJgSQjZOjy7WZdkOucFANunayPJxosQjTSUb4rePy0xm0U1XQvwfRzo_Id8oXFHg-geXWlVg4RNZUKFkKeb7Z7IAYLoEzeUROc75BQAqqsQhOVQGtGJ0QX492rfYFz48-8YPudik-JQwZx9DEbvCxfCEwQ-2Lzaxn9yUB--KV98GnIrWZ7QZv5CDzvYZv-7OE_L75vpxeVeuHm7vlz9XpeNaD6WlrWxcZ7TsbNMZBRRRmKaiTjELwDkY2lYCrVOGSYmUmgoNcBBUKa46fkIutnPnP_4ZMQ_12meHfW8DxjHXSgqujWD_hVQaZrSGGX7_B77EMYV5iZqBEAo44zO63CKXYs4Ju3qT_NqmqaZQ_y2__ih_pqe7eWOzxnYPd23P-fkut9nZvks2OJ_3TAADrszMzrYs2GFMuM_377wDoGaTug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204470323</pqid></control><display><type>article</type><title>Taxol inhibits progression of congenital polycystic kidney disease</title><source>MEDLINE</source><source>Nature Journals Online</source><source>SpringerLink Journals - AutoHoldings</source><creator>Woo, David D. L ; Miao, Steven Y. P ; Pelayo, Juan C ; Woolf, Adrian S</creator><creatorcontrib>Woo, David D. L ; Miao, Steven Y. P ; Pelayo, Juan C ; Woolf, Adrian S</creatorcontrib><description>Polycystic kidney diseases (PKD) are the most common hereditary diseases of the human kidney and account for ten per cent of patients requiring renal transplantation or dialysis. Renal cyst formation has been attributed to enhanced cell proliferation, unbalanced cell death, abnormal targeting of membrane proteins, aberrant kidney development and tubular obstruction, but there is no treatment that blocks the formation and enlargement of renal cysts. We have now developed an in vitro model of spontaneous cyst formation that distinguishes polycystic kidney epithelium from its normal counterpart. Inhibitors of DNA, RNA and protein synthesis did not prevent in vitro cyst formation, but this was reversibly inhibited by ouabain, amiloride and the microtubule-specific agents colchicine, vinblastine and taxol. The cpk mouse is a well-characterized recessive PKD model and we find that cpk/cpk mice develop PKD and die from uraemia by 4-5 weeks of age, but when treated weekly with taxol they survive for more than 200 days with minimal loss of renal function, show limited collecting-dust cyst enlargement, and attain adult size. Our results indicate that the microtubule cytoskeleton has a central role in the pathogenesis of PKD in cpk mice and that taxol may also be useful in treating human PKD.</description><identifier>ISSN: 0028-0836</identifier><identifier>EISSN: 1476-4687</identifier><identifier>DOI: 10.1038/368750a0</identifier><identifier>PMID: 7908721</identifier><identifier>CODEN: NATUAS</identifier><language>eng</language><publisher>London: Nature Publishing</publisher><subject>Animals ; Biological and medical sciences ; Body Weight - drug effects ; Cells, Cultured ; Dialysis ; Disease ; Disease Models, Animal ; Humans ; Kidney - drug effects ; Kidneys ; Medical research ; Medical sciences ; Mice ; Microtubules - drug effects ; Microtubules - physiology ; Organ Size - drug effects ; Paclitaxel - therapeutic use ; Pharmacology. Drug treatments ; Polycystic Kidney Diseases - congenital ; Polycystic Kidney Diseases - mortality ; Polycystic Kidney Diseases - prevention & control ; Protein synthesis ; Renal function ; Urinary system</subject><ispartof>Nature (London), 1994-04, Vol.368 (6473), p.750-753</ispartof><rights>1994 INIST-CNRS</rights><rights>Copyright Macmillan Journals Ltd. Apr 21, 1994</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c388t-a1d6bcf986fabf9701ee49b51c72a0033091d54eac79266e1195e9030417737f3</citedby><cites>FETCH-LOGICAL-c388t-a1d6bcf986fabf9701ee49b51c72a0033091d54eac79266e1195e9030417737f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4020379$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7908721$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Woo, David D. L</creatorcontrib><creatorcontrib>Miao, Steven Y. P</creatorcontrib><creatorcontrib>Pelayo, Juan C</creatorcontrib><creatorcontrib>Woolf, Adrian S</creatorcontrib><title>Taxol inhibits progression of congenital polycystic kidney disease</title><title>Nature (London)</title><addtitle>Nature</addtitle><description>Polycystic kidney diseases (PKD) are the most common hereditary diseases of the human kidney and account for ten per cent of patients requiring renal transplantation or dialysis. Renal cyst formation has been attributed to enhanced cell proliferation, unbalanced cell death, abnormal targeting of membrane proteins, aberrant kidney development and tubular obstruction, but there is no treatment that blocks the formation and enlargement of renal cysts. We have now developed an in vitro model of spontaneous cyst formation that distinguishes polycystic kidney epithelium from its normal counterpart. Inhibitors of DNA, RNA and protein synthesis did not prevent in vitro cyst formation, but this was reversibly inhibited by ouabain, amiloride and the microtubule-specific agents colchicine, vinblastine and taxol. The cpk mouse is a well-characterized recessive PKD model and we find that cpk/cpk mice develop PKD and die from uraemia by 4-5 weeks of age, but when treated weekly with taxol they survive for more than 200 days with minimal loss of renal function, show limited collecting-dust cyst enlargement, and attain adult size. Our results indicate that the microtubule cytoskeleton has a central role in the pathogenesis of PKD in cpk mice and that taxol may also be useful in treating human PKD.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Body Weight - drug effects</subject><subject>Cells, Cultured</subject><subject>Dialysis</subject><subject>Disease</subject><subject>Disease Models, Animal</subject><subject>Humans</subject><subject>Kidney - drug effects</subject><subject>Kidneys</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Microtubules - drug effects</subject><subject>Microtubules - physiology</subject><subject>Organ Size - drug effects</subject><subject>Paclitaxel - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Polycystic Kidney Diseases - congenital</subject><subject>Polycystic Kidney Diseases - mortality</subject><subject>Polycystic Kidney Diseases - prevention & control</subject><subject>Protein synthesis</subject><subject>Renal function</subject><subject>Urinary system</subject><issn>0028-0836</issn><issn>1476-4687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqF0Mtq3DAUBmBRGpJJWugLJJgSQjZOjy7WZdkOucFANunayPJxosQjTSUb4rePy0xm0U1XQvwfRzo_Id8oXFHg-geXWlVg4RNZUKFkKeb7Z7IAYLoEzeUROc75BQAqqsQhOVQGtGJ0QX492rfYFz48-8YPudik-JQwZx9DEbvCxfCEwQ-2Lzaxn9yUB--KV98GnIrWZ7QZv5CDzvYZv-7OE_L75vpxeVeuHm7vlz9XpeNaD6WlrWxcZ7TsbNMZBRRRmKaiTjELwDkY2lYCrVOGSYmUmgoNcBBUKa46fkIutnPnP_4ZMQ_12meHfW8DxjHXSgqujWD_hVQaZrSGGX7_B77EMYV5iZqBEAo44zO63CKXYs4Ju3qT_NqmqaZQ_y2__ih_pqe7eWOzxnYPd23P-fkut9nZvks2OJ_3TAADrszMzrYs2GFMuM_377wDoGaTug</recordid><startdate>19940421</startdate><enddate>19940421</enddate><creator>Woo, David D. L</creator><creator>Miao, Steven Y. P</creator><creator>Pelayo, Juan C</creator><creator>Woolf, Adrian S</creator><general>Nature Publishing</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7ST</scope><scope>7T5</scope><scope>7TG</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PCBAR</scope><scope>PDBOC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>R05</scope><scope>RC3</scope><scope>S0X</scope><scope>SOI</scope><scope>7QO</scope><scope>7X8</scope></search><sort><creationdate>19940421</creationdate><title>Taxol inhibits progression of congenital polycystic kidney disease</title><author>Woo, David D. L ; Miao, Steven Y. P ; Pelayo, Juan C ; Woolf, Adrian S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c388t-a1d6bcf986fabf9701ee49b51c72a0033091d54eac79266e1195e9030417737f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Body Weight - drug effects</topic><topic>Cells, Cultured</topic><topic>Dialysis</topic><topic>Disease</topic><topic>Disease Models, Animal</topic><topic>Humans</topic><topic>Kidney - drug effects</topic><topic>Kidneys</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Microtubules - drug effects</topic><topic>Microtubules - physiology</topic><topic>Organ Size - drug effects</topic><topic>Paclitaxel - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Polycystic Kidney Diseases - congenital</topic><topic>Polycystic Kidney Diseases - mortality</topic><topic>Polycystic Kidney Diseases - prevention & control</topic><topic>Protein synthesis</topic><topic>Renal function</topic><topic>Urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Woo, David D. L</creatorcontrib><creatorcontrib>Miao, Steven Y. P</creatorcontrib><creatorcontrib>Pelayo, Juan C</creatorcontrib><creatorcontrib>Woolf, Adrian S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Environment Abstracts</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Earth, Atmospheric & Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Earth, Atmospheric & Aquatic Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>University of Michigan</collection><collection>Genetics Abstracts</collection><collection>SIRS Editorial</collection><collection>Environment Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nature (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Woo, David D. L</au><au>Miao, Steven Y. P</au><au>Pelayo, Juan C</au><au>Woolf, Adrian S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Taxol inhibits progression of congenital polycystic kidney disease</atitle><jtitle>Nature (London)</jtitle><addtitle>Nature</addtitle><date>1994-04-21</date><risdate>1994</risdate><volume>368</volume><issue>6473</issue><spage>750</spage><epage>753</epage><pages>750-753</pages><issn>0028-0836</issn><eissn>1476-4687</eissn><coden>NATUAS</coden><abstract>Polycystic kidney diseases (PKD) are the most common hereditary diseases of the human kidney and account for ten per cent of patients requiring renal transplantation or dialysis. Renal cyst formation has been attributed to enhanced cell proliferation, unbalanced cell death, abnormal targeting of membrane proteins, aberrant kidney development and tubular obstruction, but there is no treatment that blocks the formation and enlargement of renal cysts. We have now developed an in vitro model of spontaneous cyst formation that distinguishes polycystic kidney epithelium from its normal counterpart. Inhibitors of DNA, RNA and protein synthesis did not prevent in vitro cyst formation, but this was reversibly inhibited by ouabain, amiloride and the microtubule-specific agents colchicine, vinblastine and taxol. The cpk mouse is a well-characterized recessive PKD model and we find that cpk/cpk mice develop PKD and die from uraemia by 4-5 weeks of age, but when treated weekly with taxol they survive for more than 200 days with minimal loss of renal function, show limited collecting-dust cyst enlargement, and attain adult size. Our results indicate that the microtubule cytoskeleton has a central role in the pathogenesis of PKD in cpk mice and that taxol may also be useful in treating human PKD.</abstract><cop>London</cop><pub>Nature Publishing</pub><pmid>7908721</pmid><doi>10.1038/368750a0</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-0836 |
| ispartof | Nature (London), 1994-04, Vol.368 (6473), p.750-753 |
| issn | 0028-0836 1476-4687 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_76438942 |
| source | MEDLINE; Nature Journals Online; SpringerLink Journals - AutoHoldings |
| subjects | Animals Biological and medical sciences Body Weight - drug effects Cells, Cultured Dialysis Disease Disease Models, Animal Humans Kidney - drug effects Kidneys Medical research Medical sciences Mice Microtubules - drug effects Microtubules - physiology Organ Size - drug effects Paclitaxel - therapeutic use Pharmacology. Drug treatments Polycystic Kidney Diseases - congenital Polycystic Kidney Diseases - mortality Polycystic Kidney Diseases - prevention & control Protein synthesis Renal function Urinary system |
| title | Taxol inhibits progression of congenital polycystic kidney disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A47%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Taxol%20inhibits%20progression%20of%20congenital%20polycystic%20kidney%20disease&rft.jtitle=Nature%20(London)&rft.au=Woo,%20David%20D.%20L&rft.date=1994-04-21&rft.volume=368&rft.issue=6473&rft.spage=750&rft.epage=753&rft.pages=750-753&rft.issn=0028-0836&rft.eissn=1476-4687&rft.coden=NATUAS&rft_id=info:doi/10.1038/368750a0&rft_dat=%3Cproquest_cross%3E4951951%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204470323&rft_id=info:pmid/7908721&rfr_iscdi=true |